OTC Markets OTCQX - Delayed Quote USD

Sonendo, Inc. (SONX)

Compare
3.5175 0.0000 (0.00%)
At close: November 25 at 3:00:00 PM EST
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
41,658.0000
43,865.0000
41,656.0000
33,197.0000
23,351.0000
Cost of Revenue
24,886.0000
33,143.0000
31,176.0000
24,861.0000
19,466.0000
Gross Profit
16,772.0000
10,722.0000
10,480.0000
8,336.0000
3,885.0000
Operating Expense
47,169.0000
66,377.0000
68,682.0000
52,481.0000
47,156.0000
Operating Income
-30,397.0000
-55,655.0000
-58,202.0000
-44,145.0000
-43,271.0000
Net Non Operating Interest Income Expense
-3,004.0000
-3,174.0000
-3,228.0000
-4,214.0000
-3,961.0000
Other Income Expense
-3,499.0000
-2,088.0000
4,382.0000
-138.0000
569.0000
Pretax Income
-36,900.0000
-60,917.0000
-57,048.0000
-48,497.0000
-46,663.0000
Tax Provision
2.0000
2.0000
2.0000
2.0000
2.0000
Net Income Common Stockholders
-32,541.0000
-60,919.0000
-57,050.0000
-48,499.0000
-46,665.0000
Diluted NI Available to Com Stockholders
-32,541.0000
-60,919.0000
-57,050.0000
-48,499.0000
-46,665.0000
Basic EPS
-69.10
-130.00
-254.00
-1.70k
-505.36
Diluted EPS
-69.10
-130.00
-254.00
-1.70k
-505.36
Basic Average Shares
473.8840
469.9430
224.6640
28.4720
92.3410
Diluted Average Shares
473.8840
469.9430
224.6640
28.4720
92.3410
Total Operating Income as Reported
-32,485.0000
-57,743.0000
-58,202.0000
-44,406.0000
-42,798.0000
Total Expenses
72,055.0000
99,520.0000
99,858.0000
77,342.0000
66,622.0000
Net Income from Continuing & Discontinued Operation
-32,541.0000
-60,919.0000
-57,050.0000
-48,499.0000
-46,665.0000
Normalized Income
-35,252.4800
-58,831.0000
-61,432.0000
-48,361.0000
-47,234.0000
Interest Expense
3,004.0000
3,174.0000
3,228.0000
4,214.0000
3,961.0000
Net Interest Income
-3,004.0000
-3,174.0000
-3,228.0000
-4,214.0000
-3,961.0000
EBIT
-33,896.0000
-57,743.0000
-53,820.0000
-44,283.0000
-42,702.0000
EBITDA
-32,325.0000
-54,768.0000
-51,004.0000
-41,286.0000
-39,135.0000
Reconciled Cost of Revenue
24,886.0000
33,143.0000
31,176.0000
24,861.0000
19,466.0000
Reconciled Depreciation
1,571.0000
2,975.0000
2,816.0000
2,997.0000
3,567.0000
Net Income from Continuing Operation Net Minority Interest
-36,902.0000
-60,919.0000
-57,050.0000
-48,499.0000
-46,665.0000
Total Unusual Items Excluding Goodwill
-2,088.0000
-2,088.0000
4,382.0000
-138.0000
569.0000
Total Unusual Items
-2,088.0000
-2,088.0000
4,382.0000
-138.0000
569.0000
Normalized EBITDA
-30,237.0000
-52,680.0000
-55,386.0000
-41,148.0000
-39,704.0000
Tax Rate for Calcs
0.0002
--
--
--
--
Tax Effect of Unusual Items
-438.4800
--
--
--
--
12/31/2020 - 11/11/2024

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

AFIB Acutus Medical, Inc.
0.0640
-1.54%
 
XTNT Xtant Medical Holdings, Inc.
0.3830
-2.08%
 
ELUT Elutia Inc.
4.0100
-6.74%
 
OPGN OpGen, Inc.
1.2940
+4.35%
 
LUNG Pulmonx Corporation
6.39
-2.89%
 
CNMD CONMED Corporation
73.32
-1.90%
 
AXGN Axogen, Inc.
14.86
+0.13%
 
NVRO Nevro Corp.
4.3100
-0.69%
 
PROF Profound Medical Corp.
7.55
-2.08%
 
RSLS ReShape Lifesciences Inc.
4.8300
-1.63%